We are live on ! Find out more
TRNS icon

Transcat

33 hedge funds and large institutions have $60M invested in Transcat in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

10% more funds holding

Funds holding: 3033 (+3)

7% more capital invested

Capital invested by funds: $56.1M → $60M (+$3.9M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

1.66% less ownership

Funds ownership: 55.3%53.64% (-1.7%)

42% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 12

Holders
33
Holders Change
+3
Holders Change %
+10%
% of All Funds
0.76%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
5
Increased
7
Reduced
12
Closed
2
Calls
Puts
Net Calls
Net Calls Change

TRNS Hedge Fund Activity: Q1 2018 in Review

33 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Transcat (TRNS) for Q1 2018, worth a combined $60M — up 6.9% from $56.1M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new TRNS positions and 2 closed out — a net gain of 3 holders — while 7 added to existing stakes and 12 trimmed.

The largest buyer was ACK Asset Management, opening a new position worth an estimated $1.1M. The largest seller was WCM Investment Management, cutting an estimated $2.71M.

  • 33 institutional investors held Transcat (TRNS) as of Q1 2018, up from 30 in Q4 2017.
  • Funds reported $60M of Transcat stock for Q1 2018, up 6.9% quarter-over-quarter.
  • 5 funds opened new Transcat positions in Q1 2018 and 2 closed out, a net change of +3 holders.
  • The largest Transcat buyer in Q1 2018 was ACK Asset Management, an estimated $1.1M added.
  • The largest Transcat seller in Q1 2018 was WCM Investment Management, an estimated $2.71M sold.

Based on aggregated 13F filings for Q1 2018.